References

1. Rao, V. and Weisel R. D., (1997) Intraoperative protection of organs: Hhypothermia, cardioplegia, and cerebroplegia,Chapter 10, in Car diac Surgery in the Adult. Edmunds, L.H. (ed.), McGraw-Hill, New York, NY, pp. 295-318.

2. Yellon, D.M., Rahimtoola, S.H., Opie, L.H., et al. (eds.). (1997) Ischemic injury and myocardial protection: evolving concepts, Jennings, R. B., and Ischemic diastolic dysfunction and postis-chemic diastolic stunning, Apstein, C. S., Varma, N., and Eberli, F. R., in New Ischemic Syndromes: Beyond Angina and Infarction. Lippincott-Raven, New York, NY, pp. 10-20, 106-114.

3. Opie, L.H. (1998) The Heart: Physiology, from Cell to Circulation. Lippincott-Raven, New York, NY, 515-589

4. Shen, Y.T. and Vatner, S.F. (1995) Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning? Circ Res. 76, 479-88.

5. Bolli, R. and Marban, E. (1999) Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 79, 609-634.

6. Karmazyn, M. and Moffat, M.P. (1993) Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res. 27, 915-924.

7. Miller, W.P., McDonald, K.S., and Moss, R.L. (1996) Onset of reduced Ca2+ sensitivity of tension during stunning in porcine myocardium. J Mol Cell Cardiol. 28, 689-697.

8. Kusuoka, H., Koretsune, Y., Chacko, V.P., et al. (1990) Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning? Circ Res. 66, 12681276.

9. McDonough, J.L., Labugger, R., Pickett, W., et al. (2001) Cardiac troponin I is modified in the myocardium of bypass patients. Circulation. 103, 58-64.

10. Opie, L.H. and du Toit, E.F. (1992) Postischemic stunning: the two-phase model for the role of calcium as pathogen. J Cardiovasc Pharmacol. 20, S1-S4.

11. Aguilera, I.M. and Vaughan, R.S. (2000) Calcium and the anaesthetist. Anaesthesia. 55, 779-790.

12. Robertie, P.G., Butterworth, J.F., Royster, R.L., et al. (1991) Normal parathyroid hormone responses to hypocalcemia during cardiopul-monary bypass. Anesthesiology. 75, 43-48.

13. Bolli, R., Patel, B.S., Jeroudi, M.O., et al. (1988) Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest. 82, 476-485.

14. Heusch, G.,and Schulz, R. (2002) Myocardial hibernation. ItalHeart J. 3, 282-284.

15. Boden, W.E., Brooks, W.W., Conrad, C.H., et al. (1995) Incomplete, delayed functional recovery late after reperfusion following acute myocardial infarction: "maimed myocardium." Am Heart J. 130, 922-932.

16. Murry, C.E., Jennings, R.B., and Reimer, K.A. (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74, 1124-1136.

17. Lawson, C.S., Coltart, D.J., and Hearse, D.J. (1993) "Dose"-depen-dency and temporal characteristics of protection by ischaemic preconditioning against ischaemia-induced arrhythmias in rat hearts. J Mol Cell Cardiol. 25, 1391-1402.

18. Schultz, J.E., Rose, E., Yao, Z., et al. (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 268, H2157-H2161.

19. Coles, J.A., Jr., Sigg, D.C., and Iaizzo, P.A. (2003) Role of kappa-opioid receptor activation in pharmacological preconditioning in swine. Am Journal Physiol Heart Circ Physiol. 284, 2091-2099.

20. Sigg, D.C., Coles, J.A., Jr., Gallagher, W.J., et al. (2001) Opioid cardioprotection: myocardial function and energy metabolism. Ann Thorac Surg. 72, 1576-1582.

21. Yellon, D.M. and Downey, J.M. (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 83, 1113-1151.

22. Gross, G.J. (2003) Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol. 35, 709-718.

23. Cohn, P.F., Fox, K.M., and Daly, C. (2003) Silent myocardial ischemia. Circulation. 108, 1263-1277.

24. Fliss, H. and Gattinger, D. (1996) Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 79, 949-956.

25. Opie, L.H. and Coetzee, W.A. (1988) Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention. Cardiovasc Drugs Ther. 2, 623-636.

26. Manning, A.S. and Hearse, D.J. (1984) Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol. 16, 497-518.

27. Wehrens, X.H., Doevendans, P.A., Ophuis, T.J., et al. (2000) A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplasty. Am Heart J. 139, 430-436.

28. Maes, A., Van de Werf, F., Nuyts, J., et al. (1995) Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. Circulation. 92, 2072-2078.

29. Forde, R.C. and Fitzgerald, D.J. (1997) Reactive oxygen species and platelet activation in reperfusion injury. Circulation. 95, 787789.

30. Menasche, P., Peynet, J., Haeffner-Cavaillon, N., et al. (1995) Influence of temperature on neutrophil trafficking during clinical car-diopulmonary bypass. Circulation. 92, II334-II340.

31. Anderson, R.E., Li, T.Q., Hindmarsh, T., et al. (1999) Increased extracellular brain water after coronary artery bypass grafting is avoided by off-pump surgery. J Cardiothorac Vasc Anesth. 13, 698702.

32. Karmazyn, M. (1998) The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury. Keio J Med. 47, 65-72.

33. Inserte, J., Garcia-Dorado, D., Ruiz-Meana, M., et al. (1997) The role of the Na+-H+ exchange occurring during hypoxia in the genesis of reoxygenation-induced myocardial oedema. J Mol Cell Cardiol. 29, 1167-1175.

34. Garcia-Dorado, D., Gonzalez, M.A., Barrabes, J.A., et al. (1997) Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na(+)-H(+) exchange. Cardiovasc Res. 35, 80-89.

35. Klein, H.H., Bohle, R.M., Pich, S., et al. (1997) Time delay of cell death by Na+/H+ exchange inhibition in regionally ischemic, reperfused porcine hearts. J Cardiovasc Pharmacol. 30, 235-240.

36. Shipolini, A.R., Yokoyama, H., Galinanes, M., et al. (1997) Na+/H+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation. 96, 3617-3625.

37. Yoshida, H. and Karmazyn, M. (2000) Na(+)/H(+) exchange inhibition attenuates hypertrophy and heart failure in 1-week post-infarction rat myocardium. Am J Physiol Heart Circ Physiol. 278, H300-H304.

38. Myers, M.L., Farhangkhoee, P., and Karmazyn, M. (1998) Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Cardiovasc Res. 40, 290-296.

39. Mathur, S. and Karmazyn, M. (1997) Interaction between anesthetics and the sodium-hydrogen exchange inhibitor HOE 642 (cari-poride) in ischemic and reperfused rat hearts. Anesthesiology. 87, 1460-1469.

40. Hartmann, M. and Decking, U.K. (1999) Blocking Na(+)-H(+) exchange by cariporide reduces Na(+)-overload in ischemia and is cardioprotective. J Mol Cell Cardiol. 31, 1985-1995.

41. Theroux, P., Chaitman, B.R., Danchin, N., et al.(2000) Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocar-dial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard During Ischemia Against Necrosis (Guardian) Investigators. Circulation. 102, 3032-3038.

42. Myers, M.L. and Karmazyn, M. (1996) Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694. Ann Thorac Surg. 61, 1400-1406.

43. Zeymer, U., Suryapranata, H., Monassier, J.P., et al. (2001) The Na+/ H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol. 38, 16441650.

44. Bugge, E. and Yterhus, K. (1995) Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart- a protective additive to ischaemic preconditioning. Cardiovasc Res. 29, 269-274.

45. Dhalla, N.S., Elmoselhi, A.B., Hata, T., et al. (2000) Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 47, 446-456.

46. Khaper, N., Rigatto, C., Seneviratne, C., et al. (1997) Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury. J Mol Cell Cardiol. 29, 3335-3344.

47. Kalaycioglu, S., Sinci, V., Imren, Y., et al. (1999) Metoprolol prevents ischemia-reperfusion injury by reducing lipid peroxidation. Jpn Circ J. 63, 718-721.

48. Feuerstein, G.Z., Yue, T.L., Cheng, H.Y., et al. (1993) Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. J Hypertens. 11, S41-S48.

49. Iyengar, S.R., Charrette, E.J., Iyengar, C.K., et al. (1976) Myocardial glycogen in prevention of perioperative ischemic injury of the heart: a preliminary report. Can J Surg. 19, 246-251.

50. Yellon, D.M. and Baxter, G.F. (1999) Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc Med. 9, 245-249.

51. Saraste, A., Pulkki, K., Kallajoki, M., et al. (1997) Apoptosis in human acute myocardial infarction. Circulation. 95, 320-323.

52. Baxter, G.F.M., Brar, B.K., Latchman, D.S., Yellon, D.M. (1998) Infarct-limiting action of transforming growth factor beta-1 in isolated rat heart is abolished. Circulation. 100, 1-9.

53. Baines, C.P., Wang, L., Cohen, M.V., et al. (1999) Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol. 94, 188-198.

54. Buerke, M., Murohara, T., Skurk, C., et al. (1995) Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 92, 8031-8035.

55. Cuevas, P., Carceller, F., Martinez-Coso, V., et al. (1999) Cardioprotection from ischemia by fibroblast growth factor: role of inducible nitric oxide synthase. Eur J Med Res. 4, 517-524.

56. Stephanou, A., Brar, B., Heads, R., et al. (1998) Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol. 30, 849-855.

57. Morita, K., Ihnken, K., Buckberg, G.D., et al. (1995) Studies of hypox-emic/reoxygenation injury: without aortic clamping. VIII. Counteraction of oxidant damage by exogenous glutamate and aspartate. J Thorac Cardiovasc Surg. 110, 1228-1234.

58. Drinkwater, D.C., Jr., Cushen, C.K., Laks, H., et al. (1992) The use of combined antegrade-retrograde infusion of blood cardioplegic solution in pediatric patients undergoing heart operations. J Thorac Cardiovasc Surg. 104, 1349-1355.

59. Nakanishi, K., Zhao, Z.Q., Vinten-Johansen, J., et al. (1995) Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg. 109, 1146-1154.

Supplements For Diabetics

Supplements For Diabetics

All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.

Get My Free Ebook


Post a comment